Thyroid hormone

This page covers all Thyroid hormone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial, Thyroid hormone receptor (TR-alpha, TR-beta), Thyroid hormone receptors.

Targets

THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial · Thyroid hormone receptor (TR-alpha, TR-beta) · Thyroid hormone receptors · Thyroid hormone receptor

Marketed (2)

• Synthroid · Generic (originally multiple — AbbVie/Synthroid) · Oncology
  Synthetic thyroxine (T4) that replaces deficient thyroid hormone, restoring normal metabolism, growth, and development.
• T3 (Triiodothyronine) · National Institute of Mental Health (NIMH) · Psychiatry / Endocrinology
  T3 (triiodothyronine) is a thyroid hormone that binds to thyroid hormone receptors in cells to increase metabolic rate and cellular energy production.

Phase 3 pipeline (1)

• T3 repletion · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Endocrinology
  T3 repletion involves the administration of triiodothyronine to replenish the body's stores of this thyroid hormone.

Phase 2 pipeline (1)

• Eltroxin administration · Meir Medical Center · Endocrinology
  Eltroxin is a synthetic form of the thyroid hormone levothyroxine, used to treat hypothyroidism.